Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01792544 · ClinicalTrials.gov registry record · NA

Clinical Reminders in Test Reports to Improve Guideline Compliance

A NA study of Echocardiography, sponsored by VA Palo Alto Health Care System.

Completed
Registry status
NA
Development phase
1,706
Enrollment target
1
Study location

NCT01792544 is a NA study of Echocardiography that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 1,706 participants, above the 385-participant average among 4 other Echocardiography trials with a reported enrollment target (343% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01792544, a NA study of Echocardiography, has completed, sponsored by VA Palo Alto Health Care System.

COMPLETED
Registry status
NA
Development phase
1,706 participants
Enrollment target
1
Study location

Study Summary

This study examines the impact of adding a statement to the echocardiography report that advises anyone reading the report regarding if and when a follow-up study is recommended.

Conditions Studied

Interventions

  • OTHER Statement
  • OTHER No Statement

Study Locations (1)

California

  • VA Palo Alto HCS - Palo Alto

Trial Details

FieldValue
Enrollment Target 1,706 participants
Start Date 2011-07
Est. Completion 2015-07
Phase NA

Sponsor

VA Palo Alto Health Care System

34 total trials

What the Registry Record Tells You About NCT01792544

The ClinicalTrials.gov registry entry for NCT01792544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,706 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 385-participant average among 4 other Echocardiography trials with a reported enrollment target (343% higher). The listed sponsor is VA Palo Alto Health Care System, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Echocardiography appearing as the primary indexed condition, and to 2 interventions - of which Statement is the first listed.

NCT01792544 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01792544 about?

NCT01792544 is a clinical study titled "Clinical Reminders in Test Reports to Improve Guideline Compliance". This study examines the impact of adding a statement to the echocardiography report that advises anyone reading the report regarding if and when a follow-up study is recommended.

What is the current status of trial NCT01792544?

This trial is currently completed. It is a NA study. The enrollment target is 1,706 participants. The study started on 2011-07. Estimated completion is 2015-07.

What conditions does trial NCT01792544 study?

This clinical trial studies the following conditions: Echocardiography.

What interventions are being tested in trial NCT01792544?

The interventions under investigation include: Statement (OTHER), No Statement (OTHER).

Who is sponsoring clinical trial NCT01792544?

This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01792544 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Echocardiography

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.